Pharmaceutical Supply Chain

USMCA Approval Signals Drug Pricing Changes Ahead

by Ana Mulero

The Senate’s January 16 approval of the US-Mexico-Canada (USMCA) Agreement was well-received by industry groups who argued for it to serve as a template for ongoing trade deal negotiations to...

GAO Flags Lack of 340B Drug Discount Program Oversight

by Ana Mulero

Weakness in the oversight of the 340B Drug Discount Program allowed some hospitals to get discounted drugs they were ineligible for, a Government Accountability Office analysis found.  Hospitals,...

CA Proposes Single Market for Drug Pricing, Manufacturing Hub

by Ana Mulero

The state of California is set to propose, as early as this spring, two initiatives to establish a single market for drug pricing within the state and a new contracting program for generic...

USMCA Makes its Way to Full Senate Vote After Lobbying Win

by Ana Mulero

The Senate Finance Committee passed the US-Mexico-Canada (USMCA) Trade Agreement of 2019 on Tuesday, in a 25-3 vote. Other senate committees are now are set to debate the trade agreement, beginning...

Data Analytics Key in 2020 Pharmaceutical Industry Predictions

by Sara Heath

As data becomes readily available and digital tools present opportunities to optimize patient and consumer relationships, pharmaceutical companies will tap the technologies necessary to boost their...

Role of Pharmacy Benefit Managers in the Pharmaceutical Supply Chain

by Sara Heath

As the healthcare industry works to tackle skyrocketing spending, a keen eye is turning toward the pharmaceutical industry. And with that, experts are examining the role pharmacy benefits managers play...